Nobility Homes Inc
OTC:NOBH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nobility Homes Inc
OTC:NOBH
|
US |
|
Qingdao Haier Biomedical Co Ltd
SSE:688139
|
CN |
Balance Sheet
Balance Sheet Decomposition
Nobility Homes Inc
Nobility Homes Inc
Balance Sheet
Nobility Homes Inc
| Nov-2002 | Nov-2003 | Nov-2004 | Nov-2005 | Nov-2006 | Nov-2007 | Nov-2008 | Oct-2009 | Nov-2010 | Nov-2011 | Nov-2012 | Nov-2013 | Nov-2014 | Oct-2015 | Nov-2016 | Nov-2017 | Nov-2018 | Nov-2019 | Oct-2020 | Nov-2021 | Nov-2022 | Nov-2023 | Nov-2024 | Nov-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
12
|
11
|
15
|
14
|
12
|
14
|
9
|
4
|
8
|
6
|
7
|
10
|
14
|
17
|
25
|
28
|
28
|
23
|
30
|
36
|
17
|
14
|
14
|
13
|
|
| Cash Equivalents |
12
|
11
|
15
|
14
|
12
|
14
|
9
|
4
|
8
|
6
|
7
|
10
|
14
|
17
|
25
|
28
|
28
|
23
|
30
|
36
|
17
|
14
|
14
|
13
|
|
| Short-Term Investments |
0
|
0
|
1
|
0
|
0
|
1
|
0
|
4
|
2
|
1
|
0
|
0
|
1
|
0
|
0
|
1
|
7
|
11
|
5
|
3
|
4
|
11
|
14
|
14
|
|
| Total Receivables |
1
|
2
|
2
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
3
|
3
|
2
|
3
|
3
|
3
|
2
|
1
|
1
|
1
|
1
|
3
|
3
|
5
|
|
| Accounts Receivables |
1
|
2
|
2
|
0
|
0
|
1
|
1
|
1
|
0
|
1
|
3
|
3
|
2
|
3
|
3
|
3
|
2
|
1
|
1
|
1
|
1
|
3
|
3
|
5
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
7
|
7
|
7
|
10
|
12
|
13
|
12
|
16
|
17
|
7
|
6
|
5
|
6
|
6
|
7
|
8
|
7
|
11
|
9
|
10
|
23
|
22
|
21
|
20
|
|
| Other Current Assets |
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
4
|
4
|
3
|
4
|
3
|
3
|
3
|
2
|
2
|
1
|
2
|
3
|
2
|
2
|
2
|
|
| Total Current Assets |
21
|
21
|
25
|
26
|
28
|
29
|
23
|
26
|
28
|
18
|
20
|
22
|
26
|
29
|
38
|
42
|
46
|
47
|
47
|
52
|
48
|
51
|
53
|
53
|
|
| PP&E Net |
3
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
5
|
5
|
6
|
7
|
8
|
8
|
8
|
8
|
|
| PP&E Gross |
3
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
0
|
0
|
0
|
5
|
5
|
6
|
7
|
8
|
8
|
8
|
8
|
|
| Accumulated Depreciation |
2
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
4
|
4
|
3
|
4
|
0
|
0
|
0
|
3
|
3
|
3
|
3
|
3
|
4
|
4
|
4
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
1
|
6
|
10
|
14
|
14
|
13
|
15
|
9
|
6
|
3
|
3
|
3
|
3
|
2
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
0
|
1
|
|
| Other Long-Term Assets |
2
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
4
|
10
|
8
|
8
|
6
|
7
|
5
|
5
|
4
|
5
|
5
|
5
|
4
|
5
|
5
|
5
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
28
N/A
|
33
+19%
|
40
+22%
|
45
+13%
|
47
+5%
|
47
+1%
|
45
-5%
|
42
-7%
|
42
-1%
|
36
-14%
|
36
-1%
|
37
+4%
|
39
+5%
|
42
+9%
|
51
+20%
|
54
+6%
|
57
+5%
|
58
+2%
|
60
+2%
|
66
+11%
|
62
-6%
|
66
+5%
|
67
+1%
|
67
+1%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Accrued Liabilities |
3
|
1
|
2
|
3
|
2
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
3
|
2
|
2
|
3
|
3
|
3
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
3
|
5
|
4
|
3
|
2
|
1
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
2
|
3
|
5
|
5
|
5
|
14
|
10
|
9
|
7
|
3
|
|
| Total Current Liabilities |
4
|
6
|
8
|
8
|
5
|
4
|
1
|
1
|
1
|
2
|
1
|
2
|
2
|
3
|
5
|
6
|
8
|
9
|
8
|
17
|
14
|
13
|
10
|
6
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
4
N/A
|
6
+58%
|
9
+46%
|
8
-7%
|
5
-32%
|
4
-35%
|
2
-51%
|
1
-53%
|
1
+36%
|
2
+66%
|
1
-25%
|
2
+43%
|
2
+21%
|
3
+41%
|
6
+87%
|
7
+8%
|
8
+18%
|
9
+13%
|
9
-1%
|
17
+90%
|
14
-14%
|
13
-10%
|
10
-23%
|
6
-36%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
22
|
26
|
30
|
35
|
40
|
42
|
42
|
40
|
39
|
33
|
33
|
33
|
35
|
37
|
43
|
46
|
50
|
55
|
58
|
60
|
63
|
71
|
75
|
79
|
|
| Additional Paid In Capital |
9
|
9
|
9
|
9
|
10
|
10
|
10
|
10
|
10
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
|
| Treasury Stock |
8
|
8
|
8
|
8
|
9
|
9
|
9
|
10
|
10
|
10
|
10
|
10
|
9
|
10
|
10
|
10
|
13
|
17
|
18
|
22
|
27
|
30
|
30
|
30
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
24
N/A
|
27
+13%
|
31
+17%
|
37
+18%
|
42
+12%
|
44
+5%
|
43
-1%
|
41
-5%
|
41
-1%
|
34
-16%
|
34
+0%
|
35
+3%
|
37
+4%
|
39
+7%
|
45
+14%
|
47
+6%
|
49
+3%
|
49
+1%
|
51
+3%
|
49
-3%
|
48
-3%
|
53
+10%
|
57
+7%
|
61
+7%
|
|
| Total Liabilities & Equity |
28
N/A
|
33
+19%
|
40
+22%
|
45
+13%
|
47
+5%
|
47
+1%
|
45
-5%
|
42
-7%
|
42
-1%
|
36
-14%
|
36
-1%
|
37
+4%
|
39
+5%
|
42
+9%
|
51
+20%
|
54
+6%
|
57
+5%
|
58
+2%
|
60
+2%
|
66
+11%
|
62
-6%
|
66
+5%
|
67
+1%
|
67
+1%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
3
|
3
|
3
|
3
|
|